Zio ECG Utilization Software (ZEUS) System vs Eko Low Ejection Fraction Tool (ELEFT)

Eko Low Ejection Fraction Tool (ELEFT) offers a more immediate and integrated point-of-care experience by leveraging a familiar tool (digital stethoscope) and providing rapid results within approximately 15 seconds during routine physical exams. This direct, real-time interaction during a patient encounter suggests a highly streamlined user experience. In contrast, Zio ECG Utilization Software (ZEUS) System involves continuous monitoring and subsequent report review, which, while supported by a mobile app, represents a less immediate interaction in the clinical workflow.

Zio ECG Utilization Software (ZEUS) System provides comprehensive, long-term continuous ECG monitoring for up to 14 days, offering a deeper diagnostic picture for a wide range of cardiac arrhythmias. Its AI algorithm is clinically proven to perform at the level of cardiologists with a 99% physician agreement rate, and studies demonstrate its impact on reducing cardiovascular events and improving health outcomes. While Eko Low Ejection Fraction Tool (ELEFT) is valuable for early heart failure screening, it serves as a point-of-care screening tool rather than a comprehensive diagnostic and management system.

While both tools require contacting sales for specific pricing, Eko's ELEFT, as part of the SENSORA platform, has a publicly established CMS reimbursement rate of $128.90 per use, effective July 2025. This transparency and clear reimbursement pathway offer a more predictable value proposition for healthcare providers. Zio ECG Utilization Software (ZEUS) System, despite having insurance coverage and adjusted reimbursement rates, involves a more complex billing process for the device and service.

Both tools demonstrate strong enterprise readiness. Both are cloud-based, FDA-cleared, HIPAA compliant, and have Business Associate Agreements (BAAs). Tool A explicitly mentions HL7-based EHR integration, a key enterprise feature. Tool B is part of an enterprise platform (SENSORAu2122), is MDSAP and ISO certified, and is purpose-built for telemedicine, indicating robust integration and scalability for health systems. Given these comprehensive features, neither tool clearly surpasses the other in overall enterprise readiness.

Eko Low Ejection Fraction Tool (ELEFT) demonstrates greater innovation by integrating an FDA-cleared AI algorithm with digital stethoscopes for rapid, non-invasive detection of low ejection fraction at the point of care. This application of AI to a common clinical tool for immediate diagnostic support during a routine physical exam represents a more disruptive and novel approach to early disease detection in primary care settings. While Tool A offers advanced long-term monitoring, Tool B's immediate, integrated point-of-care diagnostic capability is a more significant leap in accessibility and immediate clinical utility.

Both companies provide comprehensive support and documentation. iRhythm Technologies offers 24/7 patient support via phone and email, along with a Clinical Resource Center and readily available user manuals and FAQs. Eko Health provides a help center, various contact options including live demos and scheduled calls, and readily available user manuals for its products, including ELEFT. Both appear to offer robust resources for both patients and healthcare professionals.